Correction of serum chloride concentration in dogs with congestive heart failure

Darcy Adin1, Clarke Atkins2, Leonel Londoño1

  • 1University of Florida, College of Veterinary Medicine, Gainesville, Florida, USA.

Insights

In dogs with advanced heart failure, corrected chloride levels were higher than measured levels, indicating water retention. However, hypochloremia persisted due to diuretic effects.

Area of Science:

  • Veterinary Cardiology
  • Canine Pathophysiology
  • Electrolyte Imbalances

Background:

  • Hypochloremia in dogs with congestive heart failure (CHF) is complex, influenced by loop diuretics causing sodium and chloride loss and water retention causing dilution.
  • Mathematical correction of chloride levels can help differentiate these effects.

Purpose of the Study:

  • To evaluate if corrected chloride levels (c[Cl-]) differ from measured chloride levels (m[Cl-]) in dogs with varying stages of CHF.
  • To determine if higher c[Cl-] compared to m[Cl-] in refractory CHF indicates relative water excess.

Main Methods:

  • Retrospective analysis of clinicopathological data from dogs with no CHF, Stage C CHF, and Stage D CHF.
  • Calculation of c[Cl-] using a formula based on sodium levels and m[Cl-].
  • Comparison of c[Cl-] and m[Cl-] across different CHF stages.

Main Results:

  • Serum chloride levels (both corrected and measured) were significantly lower in Stage D CHF dogs compared to Stage C and no CHF dogs.
  • Corrected chloride levels were higher than measured levels in Stage D CHF dogs, but not in Stage C or no CHF dogs.
  • While corrected chloride levels suggested relative water excess in Stage D CHF, persistent hypochloremia was noted, consistent with diuretic use.

Conclusions:

  • Mathematical correction of serum chloride levels revealed a relative water excess in dogs with Stage D CHF.
  • Despite evidence of water retention, hypochloremia persisted in advanced CHF, likely due to the effects of loop diuretics on electrolytes.
  • Further research correlating corrected chloride levels with antidiuretic hormone is recommended.
Abstract

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
119
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
633
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
100
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
197
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
274
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
200